FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes
Titel:
FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes
Auteur:
de Poel, E. Spelier, S. Hagemeijer, M.C. van Mourik, P. Suen, S.W.F. Vonk, A.M. Brunsveld, J.E. Ithakisiou, G.N. Kruisselbrink, E. Oppelaar, H. Berkers, G. de Winter de Groot, K.M. Heida-Michel, S. Jans, S.R. van Panhuis, H. Bakker, M. van der Meer, R. Roukema, J. Dompeling, E. Weersink, E.J.M. Koppelman, G.H. Blaazer, A.R. Muijlwijk-Koezen, J.E. van der Ent, C.K. Beekman, J.M.